These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10319084)

  • 21. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
    Ekelund U
    Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
    Koh E; Morimoto S; Tomita J; Rakugi H; Jiang B; Inoue T; Nabata T; Fukuo K; Ogihara T
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):175-9. PubMed ID: 7511744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac and vascular actions of decapeptide angiotensin analogs.
    Baker KM; Khosla MC
    J Pharmacol Exp Ther; 1986 Dec; 239(3):790-6. PubMed ID: 3025418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component.
    Neri Serneri GG; Boddi M; Modesti PA; Coppo M; Cecioni I; Toscano T; Papa ML; Bandinelli M; Lisi GF; Chiavarelli M
    Circ Res; 2004 Jun; 94(12):1630-7. PubMed ID: 15131005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Direct cardiac effects of angiotensins I and II and 2 converting enzyme inhibitors (captopril and perindopril). Indirect demonstration of a converting enzyme in the rat heart].
    Diebold H; Moreau D; Chardigny JM; Rochette L
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():29-32. PubMed ID: 2847675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of bradykinin and the ischemic isolated rat heart.
    Tio RA; van Gilst WH; Rett K; Wolters K; Dietze GJ; Wesseling H
    Horm Metab Res Suppl; 1990; 22():85-9. PubMed ID: 2167866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.
    Weber KT; Sun Y; Tyagi SC; Cleutjens JP
    J Mol Cell Cardiol; 1994 Mar; 26(3):279-92. PubMed ID: 8028011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac renin-angiotensin system. Molecular and functional aspects.
    Dzau VJ
    Am J Med; 1988 Mar; 84(3A):22-7. PubMed ID: 3218653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of endothelial cell function for angiotensin conversion in serial-arranged arterioles.
    Tang T; Connelly BA; Joyner WL
    J Vasc Res; 1995; 32(2):129-37. PubMed ID: 7734659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance.
    Gibbons GH
    Drugs; 1997; 54 Suppl 5():1-11. PubMed ID: 9429840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The potential clinical strategies for prevention and treatment of ischemic/hypoxic myocardial damage following severe burns].
    Huang YS
    Zhonghua Shao Shang Za Zhi; 2007 Jun; 23(3):161-3. PubMed ID: 18019050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle.
    Robertson AL; Khairallah PA
    Science; 1971 Jun; 172(3988):1138-9. PubMed ID: 4324923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II blockers improve cardiac coronary flow under hemodynamic pressure overload.
    Chang WT; Fisch S; Dangwal S; Chen M; Cheng S; Chen ZC; Liao R
    Hypertens Res; 2021 Jul; 44(7):803-812. PubMed ID: 33568793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgE-Mediated Systemic Anaphylaxis And Its Association With Gene Polymorphisms Of ACE, Angiotensinogen And Chymase.
    Varney VA; Nicholas A; Warner A; Sumar N
    J Asthma Allergy; 2019; 12():343-361. PubMed ID: 31632094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts.
    Nuñez RE; Javadov S; Escobales N
    Pflugers Arch; 2018 Sep; 470(9):1391-1403. PubMed ID: 29748710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conducting the G-protein Coupled Receptor (GPCR) Signaling Symphony in Cardiovascular Diseases: New Therapeutic Approaches.
    Belmonte SL; Blaxall BC
    Drug Discov Today Dis Models; 2012; 9(3):e85-e90. PubMed ID: 23162605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease.
    John SG; Owen PJ; Harrison LE; Szeto CC; Lai KB; Li PK; McIntyre CW
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2389-94. PubMed ID: 21852662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac production of angiotensin II and its pharmacologic inhibition: effects on the coronary circulation.
    Schmermund A; Lerman LO; Ritman EL; Rumberger JA
    Mayo Clin Proc; 1999 May; 74(5):503-13. PubMed ID: 10319084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.